DMTweet

a tweet recap by PsyMed Ventures x Business Trip colab (issue #12)

🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄

DMTweet is a newsletter of psychedelic tweets that catch our eye 👀.

This is a collaboration between PsyMed Ventures and Business Trip (yes, we’re the folks working on both 🙃).

Tweets include: Industry updates 💼, Therapy 🛋️, Psychedelic research 🧪, Neuroscience 🧠, Consciousness ✨, Indigenous reciprocity ⚖️, Regulatory updates 📜, and Trippy ideas 👽.

Inclusion = interesting ≠ endorsement.

Let’s get to it….

Josh Hardman @Josh__Hardman

Elias Dakwar is back at Horizons this year presenting ‘Lifting the veil of hope and hype’ Just as relevant and biting this year as the last.

Blossom @blossomact

Using a language model to predict who will benefit from psychedelic therapy? Researchers in collaboration with @COMPASSPathway find that recordings from the therapy sessions can predict outcomes 12 weeks later with 85% accuracy A mini thread 🧵

Boris D Heifets @TheBorisLab

I’m usually first to see confounds in our own data— but the massive placebo effect is hard to miss. And I don’t think it’s because sevoflurane and propofol are potent antidepressants at the doses we used- more detail to come as we finish analysis

Samuel Kohtala @samuelkohtala

@MichaelHaichin @TheBorisLab Important implications for psychedelic studies

Balázs Szigeti @psybalazs

"Does it matter whether microdosers feel better because of the drug or the #placebo effect?" - paraphrasing a question I got at the #ICPR2022 #microdose session. I wanted to share my response here as it is a good question, a short 🧵👇

James Close @jamesbclose

🦠🔬DMT and Psilocin Change Microglia Immunological Phenotype - more pre-clinical evidence for an anti-inflammatory & pro-immune mechanism of #psychedelics: biorxiv.org/content/biorxi… @REMAPTherapy @PainResForum

Josh Hardman @Josh__Hardman

What pain point(s) do you envisage psychedelic-assisted therapy providers will have to deal with in the coming years? Lesser-discussed wrinkles are especially welcomed...

Jerry Tang @jerryptang

very excited to share our paper on reconstructing language from non-invasive brain recordings! we introduce a decoder that takes in fMRI recordings and generates continuous language descriptions of perceived speech, imagined speech, and possibly much more

biorxiv.orgSemantic reconstruction of continuous language from non-invasive brain recordingsA brain-computer interface that decodes continuous language from non-invasive recordings would have many scientific and practical applications. Currently, however, decoders that reconstruct continuous language use invasive recordings from surgically implanted electrodes[1][1]–[3][2], while decoders…

Ruben Laukkonen @RubenLaukkonen

I have a wild ambulance IV #ketamine story that I feel like I have to share. I told it to my students in a class on the plasticity of #consciousness and they insisted it needs to be public knowledge. So, somewhat apprehensibly, here it is. Strap in 📜:

Andrew D. Huberman, Ph.D. @hubermanlab

New Huberman Lab Podcast out: PSYCHEDELICS & NEUROSTIMULATION FOR REWIRING THE BRAIN w/Dr Nolan Williams MD @NolanRyWilliams of @StanfordMed • Treating Depression • TMS • Ibogaine, MDMA, DMT, LSD • Psylocibin, Cannabis, SSRIs • Safety, Risks, Etc.

hubermanlab.comDr. Nolan Williams: Psychedelics & Neurostimulation for Brain RewiringNolan Williams, M.D., a triple board-certified psychiatrist, neurologist and professor of psychiatry and behavioral sciences at Stanford School of Medicine.

Dr. Jen Wolkin | ADHD + Trauma + Anxiety Info @drjenwolkin

Rest is NOT a reward. (It’s a neurobiological imperative) And, does NOT need to be earned.

Greg Kubin @kubeans

join our squad! or if you know someone who'd be a fit for the role below, pls send them our way.

PsyMed Ventures @PsymedVentures

We’re hiring an Operations Associate at PsyMed Ventures. This team member will help us streamline our operations, improve communications, and support our portfolio companies and LP community. Is this for you? Apply here: https://t.co/sLWyFXtteb

Until next time,

Greg & Matias

🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄

DMTweet is a collab between PsyMed Ventures and Business Trip. PsyMed Ventures is a community-focused fund and syndicate investing in psychedelic medicine and mental health tech. Business Trip is a podcast about psychedelic entrepreneurship. Our mission is to help expand access to psychedelic medicine and mental health.

Thanks for reading DMTweet! Subscribe to receive new posts and Business Trip podcast episodes.